Identification of Microbial DNA in Maternal Plasma After PPROM

NCT04318470 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2023-04-07

No results posted yet for this study

Summary

This study evaluates the use of metagenomic next generation sequencing in identifying microbial DNA in plasma samples of patients with preterm premature rupture of membranes.

Conditions

  • Preterm Rupture of Membranes

Interventions

DIAGNOSTIC_TEST

mNGS

Metagenomic next generation sequencing for microbial DNA

Sponsors & Collaborators

Principal Investigators

  • Nasim C Sobhani, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-12
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04318470 on ClinicalTrials.gov